3B BlackBio Dx Ltd approves Q2 FY27 results, with consolidated net profit of ₹1,802.33 lakh
- Consolidated revenue was ₹4,828.02 lakh for the quarter ended 30 September 2026, up 42.4% YoY and 44.2% QoQ.
- Net profit rose 19.9% YoY and 100.7% QoQ.
- Statutory auditor’s limited review reported no indication of material misstatement; subsidiary results were unaudited and not material to the Group.
